๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2759245 4 F NC 04/04/2024 DTPPVHBHPB
HEPA
MMR
HEPA
 MSP VACCINE COMPANY
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 U7788AA
W038118
X007688
W038118
Incorrect dose administered, No adverse event; Incorrect dose administered, No a... Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event More
Patient was given an Adult dose of Hepatitis Vaqta-Adult instead of a pediatric dose. No treatment ... Patient was given an Adult dose of Hepatitis Vaqta-Adult instead of a pediatric dose. No treatment was needed, follow up with patient per mother states no side effects. More
1159817 34 F OH 04/02/2021 COVID19
COVID19
 MODERNA
MODERNA
017B21A
Axillary pain, Induration, Injection site reaction, Rash macular, Skin warm; Ery... Axillary pain, Induration, Injection site reaction, Rash macular, Skin warm; Erythema, Joint swelling, Lymphadenopathy, Pruritus, Skin warm More
Giant red splotch 1 inch below injection site approximately the size of an orange, slightly inflamed... Giant red splotch 1 inch below injection site approximately the size of an orange, slightly inflamed and warm. Hard to the touch. Slight pain in underarm lymph node. Nothing that impeded daily activities. More
2832692 31 M 03/22/2025 COVID19
 NOVAVAX
Palpitations Palpitations
Heart palpitations. Heart palpitations.
2832693 25 F IN 03/22/2025 COVID19
FLU3
HEP
HEPA
IPV
VARCEL
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
DYNAVAX TECHNOLOGIES CORPORATION
GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
MERCK & CO. INC.
 8081260
4S5YG
944916
4T93R
W1c751M
Y010184
Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product... Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product use issue; Exposure during pregnancy, Product use issue More
The patient presented to our vaccine clinic on 1/27/2025 for immigration vaccines. On the health que... The patient presented to our vaccine clinic on 1/27/2025 for immigration vaccines. On the health questionnaire, she did not indicate that she was pregnant. Our staff does not recall the pt being "visibly pregnant". A live virus vaccine, varicella was administered. On March 20th, Dr. contacted our clinic asking why the pt was given a live virus vaccine while pregnant. Per Dr., the pt was 32 weeks pregnant at the time of vaccination on 1/27/2025. I informed Dr. that the pt did not indicate she was pregnant on her health questionnaire and that I would report the incident to VAERS. More
2832694 16 M NC 03/22/2025 MNP
 GLAXOSMITHKLINE BIOLOGICALS
Arthralgia, Loss of personal independence in daily activities Arthralgia, Loss of personal independence in daily activities
Provider indicated SIRVA. My son is now several weeks out from injection date and still experiencin... Provider indicated SIRVA. My son is now several weeks out from injection date and still experiencing severe pain in his shoulder that is negatively impacting his daily living. More
2832695 64 M FL 03/22/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 l5229
Inappropriate schedule of product administration Inappropriate schedule of product administration
duplicate vaccine within 10 year timeframe duplicate vaccine within 10 year timeframe
2832696 0.33 M 03/22/2025 FLU3
HEP
HIBV
PNC13
RV5
 SEQIRUS, INC.
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
PFIZER\WYETH
MERCK & CO. INC.




Pyrexia; Pyrexia; Pyrexia; Pyrexia; Pyrexia Pyrexia; Pyrexia; Pyrexia; Pyrexia; Pyrexia
Fever , concerns for aseptic meningitis Fever , concerns for aseptic meningitis
โœ“
2832697 72 F IA 03/22/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 TS525
No adverse event No adverse event
There was no adverse reaction that occurred. The wrong vaccine was administered. The patient was w... There was no adverse reaction that occurred. The wrong vaccine was administered. The patient was wanting to receive the Covid vaccine and received the Shingrix vaccine in error. More
2832698 69 F MO 03/22/2025 FLU3
 SEQIRUS, INC.
 388487
Musculoskeletal stiffness, Pain in extremity Musculoskeletal stiffness, Pain in extremity
The patient stated that she had severe soreness and stiffness in her arm a few days after receiving ... The patient stated that she had severe soreness and stiffness in her arm a few days after receiving the vaccine that has persisted over the last few months. The patient perceived that it may have been due to the location the vaccine was given. She sought medical treatment from her provider due to the persistent soreness and he prescribed the patient medications to help with the pain and stiffness and suggested physical therapy . More
2832699 74 F MI 03/22/2025 PNC21
 MERCK & CO. INC.
 y013009
Pain, Peripheral swelling, Rash, Rash erythematous Pain, Peripheral swelling, Rash, Rash erythematous
Night of vaccination administration, patient felt pain (worse than normal local pain), next morning ... Night of vaccination administration, patient felt pain (worse than normal local pain), next morning patient noticed her arm was swollen and red rash had developed. When patient reported to pharmacy (3/22/25) rash was still slightly visible, appearing further down the arm as vaccine had traveled through muscle. More
2832700 62 F GA 03/22/2025 COVID19
 MODERNA
 066H21A
Fatigue, Injection site pruritus, Musculoskeletal stiffness, Pain in extremity, ... Fatigue, Injection site pruritus, Musculoskeletal stiffness, Pain in extremity, Tinnitus More
I have had ringing in my ears ever since a few days after this shot. The location of the shot hurt q... I have had ringing in my ears ever since a few days after this shot. The location of the shot hurt quite a bit after the shot for a few days, and I was extremely tired. Then the ringing started and it has never quit. I spoke to an ENT about this, but he said there was nothing that could be done. I also experienced stabbing pains in my lower legs for several months, but those have gone away. Now I just have a lot more stiffness than I used to. More
2832701 68 F AK 03/22/2025 PNC20
 PFIZER\WYETH
 lg5577
Acute myocardial infarction, Coronary arterial stent insertion Acute myocardial infarction, Coronary arterial stent insertion
Experienced a myocardial infarction (NSTEMI) and stent placement in the LAD 2 days after vaccination... Experienced a myocardial infarction (NSTEMI) and stent placement in the LAD 2 days after vaccination with PCV20. More
โœ“ โœ“
2832702 75 M GA 03/22/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 L5229
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient received Boostrix vaccine previously on 12/2/2024 and again on 3/21/2025. This is an admini... Patient received Boostrix vaccine previously on 12/2/2024 and again on 3/21/2025. This is an administration error. Patient had no adverse reaction or side effects. More
2832703 71 F AL 03/22/2025 PNC20
 PFIZER\WYETH
 LK6651
Injection site erythema, Injection site pruritus, Injection site swelling Injection site erythema, Injection site pruritus, Injection site swelling
Redness, swelling and itching 3 inches around injection site Redness, swelling and itching 3 inches around injection site
2832704 65 M OH 03/22/2025 PNC20
PNC20
 PFIZER\WYETH
PFIZER\WYETH

Arthralgia, Fatigue, Headache, Injection site erythema, Injection site swelling;... Arthralgia, Fatigue, Headache, Injection site erythema, Injection site swelling; Myalgia More
swelling and redness at the injection site; redness spread to bicep of arm injected; fatigue, muscle... swelling and redness at the injection site; redness spread to bicep of arm injected; fatigue, muscle and joint pain; headache More
2832705 63 F FL 03/22/2025 PNC20
TDAP
 PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
 LK6650
L5229
Erythema, Peripheral swelling, Skin warm, Tenderness; Erythema, Peripheral swell... Erythema, Peripheral swelling, Skin warm, Tenderness; Erythema, Peripheral swelling, Skin warm, Tenderness More
The following day patient presented with left arm tenderness, red and slightly swollen and warm to t... The following day patient presented with left arm tenderness, red and slightly swollen and warm to touch. Presentation has lasted all week. Also pain in the left hand present. Patient asked for consult today 7 days after vaccination for treatment and will use a cortisone cream and aleve More
2832706 24 F NC 03/22/2025 HPV9
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.


Computerised tomogram normal, Erythema, Fibrin D dimer, Mobility decreased, Pain... Computerised tomogram normal, Erythema, Fibrin D dimer, Mobility decreased, Pain in extremity; Peripheral swelling, Pruritus, Scan with contrast normal, Swelling face, Ultrasound neck; Urticaria More
03/21/2025: Swollen face and forehead. Itchy forehead, swollen lip on left side. Pain in hands. 03/... 03/21/2025: Swollen face and forehead. Itchy forehead, swollen lip on left side. Pain in hands. 03/22/2025: swollen chin, swollen hands, cannot close hands or move fingers. Red hives on left arm, extra swelling and pain on left hand. More
2832707 56 F WA 03/22/2025 PNC20
 PFIZER\WYETH
 LX2497
Injection site pruritus, Injection site swelling, Injection site urticaria, Mala... Injection site pruritus, Injection site swelling, Injection site urticaria, Malaise, Pyrexia More
My arm is still swollen on the side of the injection. 24 hrs after getting the vaccination I felt ve... My arm is still swollen on the side of the injection. 24 hrs after getting the vaccination I felt very ill with a fever of 101. Most notable, was my arm swelling and itching with hives around the injection site. I took Benadryl and used an antihistamine ointment. I have never felt this ill from a vaccination. More
2832708 64 F TX 03/22/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 N77J2
N77J2
Head discomfort, Mobility decreased, Peripheral swelling, Posture abnormal, Prur... Head discomfort, Mobility decreased, Peripheral swelling, Posture abnormal, Pruritus; Pyrexia, Rash, Urticaria More
Pt stated she had internal and external itching with whole head being so heavy she couldn't lif... Pt stated she had internal and external itching with whole head being so heavy she couldn't lift it up for 7 days; arm swelled up the size of a baseball and couldn't lift her arm; rash/hives all over her body; fever 101F with which she took Tyl q 4 h for 2 days More
2832709 45 M WA 03/22/2025 COVID19
 MODERNA
Atrial fibrillation, Cardioversion, Magnetic resonance imaging head abnormal Atrial fibrillation, Cardioversion, Magnetic resonance imaging head abnormal
1/29/21 and 2/26/21 moderna vaccination. I was first seen on 7/29/21 foer afib in emergency roo... 1/29/21 and 2/26/21 moderna vaccination. I was first seen on 7/29/21 foer afib in emergency room. I now have chronic constant afib. I have had 2 failed cardioversions. All medications can't keep me out of afib. I now have an abnormal brain mri and will be going in for heart ablasion on March 31st. More
2832710 40 F NJ 03/22/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
 011L20A
011L20A
011L20A
011L20A
031L20A
031L20A
031L20A
031L20A
Alopecia, Asthenia, Autoimmune thyroiditis, Blood test abnormal, Chronic fatigue... Alopecia, Asthenia, Autoimmune thyroiditis, Blood test abnormal, Chronic fatigue syndrome; Cognitive disorder, Condition aggravated, Fatigue, Feeling of body temperature change, Hypersomnia; Impaired work ability, Loss of employment, Memory impairment, Mobility decreased, Post-acute COVID-19 syndrome; Postural orthostatic tachycardia syndrome, Somnolence; Alopecia, Asthenia, Autoimmune thyroiditis, Blood test abnormal, Chronic fatigue syndrome; Cognitive disorder, Condition aggravated, Fatigue, Feeling of body temperature change, Hypersomnia; Impaired work ability, Loss of employment, Memory impairment, Mobility decreased, Post-acute COVID-19 syndrome; Postural orthostatic tachycardia syndrome, Somnolence More
A few weeks after the second dose of the vaccine I began getting very tired and weak. Over the next... A few weeks after the second dose of the vaccine I began getting very tired and weak. Over the next few weeks after that I became devoid of all energy and had extreme difficulty waking up in the morning. This turned into sleeping 16-18 hours a day. As well as such extreme tiredness I couldn?t fully wake up in order to work my part time job. The weakness continued until I became basically bed ridden for almost 2 full years. I had a very noticeable change in memory as well as cognitive ability. I began experiencing extreme changes in temperature and feeling very weak when I stood. These symptoms did not change and continue to this day. More
โœ“
2832472 4 PA 03/21/2025 MMRV
 MERCK & CO. INC.
 Y015356
Device leakage, No adverse event Device leakage, No adverse event
No additional adverse events were reported; The vaccine began leaking out between the syringe and t... No additional adverse events were reported; The vaccine began leaking out between the syringe and the luer lock; the needle was in the patient's arm; This spontaneous report was received from a Registered Nurse (RN) and refers to a 4-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 21-FEB-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y015356, expiration date: 10-MAR-2026) for prophylaxis (dose, route and site of administration were not reported) using a sterile diluent (BAXTER Sterile Diluent), (lot #2031275, expiration date: 15-Dec-2026). The RN said the syringe contained reconstituted Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) and was being administered to patient and the needle was in the patient's arm (poor quality device used), but then the vaccine began leaking out between the syringe and the luer lock (device leakage). The RN said she believed that when the needle was attached to prefilled syringes of sterile diluent (BAXTER Sterile Diluent ) that it created a suction and made it where the luer lock loosens. No additional adverse events were reported (no adverse event).; Sender's Comments: Priority : 5 , Is case serious : No , MNSC number : 02757689-02757684 , CLIC number : , ESTAR number : , IRMS number : 500UW00000UKnBWYA1|10032025120014|1860 , Central date : 2025-03-10 , Classification : DMC, Attachment description : NSC Call , Safety case number : 2258717 , MNSC case number : 02757689 , MNSC interaction number : 02757684 , Integration log UniqueID : 500UW00000UKnBWYA1|10032025120014|1860 , Service cloud CaseID : 500UW00000UKnBWYA1 More
2832473 F 03/21/2025 IPV
IPV
MMR
MMR
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER



Attention deficit hyperactivity disorder, Cerebral disorder, Discomfort, Fatigue... Attention deficit hyperactivity disorder, Cerebral disorder, Discomfort, Fatigue, Feeling abnormal; Loss of consciousness, Narcolepsy, Pain, Quality of life decreased, Sleep disorder; Attention deficit hyperactivity disorder, Cerebral disorder, Discomfort, Fatigue, Feeling abnormal; Loss of consciousness, Narcolepsy, Pain, Quality of life decreased, Sleep disorder More
She then developed narcolepsy/blacked out; Felt differently afterward; Her brain has been messed up ... She then developed narcolepsy/blacked out; Felt differently afterward; Her brain has been messed up ever/She always feels brain damage; she slept harder after being vaccinated,; her life has been messed up; she's always still tired; ADHD; This spontaneous report was received from a 40-year-old female patient, concerning herself. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On unknown day (reported as when she was 3 and a half years old), the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-RII) (strength, dose, route of administration, anatomical location, lot #, and expiry date were not provided) which was diluted with sterile diluent (expiration date and lot # were not reported) as prophylaxis and an with an unspecified polio vaccine (indication, dose, route of administration, anatomical location, expiration date, and lot # were not reported). On an unspecified day, the patient reported that her life has been messed up since she received her childhood vaccinations (quality of life decreased). She blacked out and felt differently afterward (feeling abnormal). In addition, she said her brain has been messed up ever since (cerebral disorder) and always felt brain damaged. She stated she has never been the same (she was normal before these vaccines and at the time of the report she was a totally different person). She then developed narcolepsy and ADHD (attention deficit hyperactivity disorder) as a result of a vaccine. Consumer stated she needs ADHD medicine for her brain and to not develop hypoglycemia and she was afraid she would be hypoglycemic if she stopped taking it. She could not function without the ADHD medication. Consumer was concerned that she didn't need these medications when she was a child and blamed vaccinations for her needing them at the time of report. Moreover, the patient informe that she slept harder (sleep disorder) after being vaccinated, but she was always still tired (fatigue). She felt like something was beating her down and felt like a city was weighing or a heavy building was sitting on her. She also felt like kept getting hit by a mac truck. She experienced a "dragging effect" like gravity was pulling was her down. "She could not get that gravity feel off of her". At the reporting time, the outcome of all the events was not provided. The reporter considered the events of narcolepsy, cerebral disorder, and ADHD to be related to the suspect vaccines/therapy. While the causal relationship between the remained events and the suspect vaccines/therapy was not provided. Upon internal review, the event of narcolepsy was determined to be medically significant. More
2832474 34 UT 03/21/2025 HPV9
 MERCK & CO. INC.
 W026152
Expired product administered, No adverse event Expired product administered, No adverse event
No additional AE/PQC reported; Customer called to report expired GARDASIL 9 administered to a patien... No additional AE/PQC reported; Customer called to report expired GARDASIL 9 administered to a patient post product expiration. Expiration date was 29JAN2025. Product was administered on 14MAR2025. No TE occurred. No symptoms reported. Caller consented to correspondence. See r; This spontaneous report was received from a nurse, concerning to a 34-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-Mar-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant, at a dose of 0.5 mL, administered as prophylaxis (route of administration was not provided; lot #W026152 has been verified to be valid for this vaccine, expiration date reported and confirmed as 29-Jan-2025); which was an expired vaccine (Expired product administered). No additional adverse event was reported (No adverse event). More
2832476 1.25 F WA 03/21/2025 HIBV
 SANOFI PASTEUR
 UK093AB
No adverse event, Product preparation error No adverse event, Product preparation error
administration of ACTHIB with the wrong diluent with no reported ae; Initial information received on... administration of ACTHIB with the wrong diluent with no reported ae; Initial information received on 17-Mar-2025 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to US-SA-2025SA079766. This case involves a 15 months old female patient who had administration of HIB (PRP/T) vaccine [ACT-HIB] with the wrong diluent with no reported AE (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Influenza vaccine (Flu) for Immunisation; and (Pneumococcal vaccines) for Immunisation. On 13-Mar-2025, the patient received a 0.5ml dose 4 of suspect HIB (PRP/T) vaccine (lot UK093AB) Powder and solvent for solution for injection standard strength, frequency-once (expiry date-30-Sep-2025) via intramuscular route in the right vastus lateralis for immunization and with the wrong diluent with no reported ae (product preparation error) (latency-same day). Reportedly-Nurse called to get information about reconstituting ACTHIB with a different diluent (sterile water), which was administered to 2 patients. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA079766: More
2832484 AZ 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Neuralgia, Rash Neuralgia, Rash
Rash following administration of Shingrix; nerve pain following administration of Shingrix; This ser... Rash following administration of Shingrix; nerve pain following administration of Shingrix; This serious case was reported by a physician via sales rep and described the occurrence of rash in a elderly patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: Rash following administration of Shingrix) (serious criteria other: serious as per reporter) and nerve pain (Verbatim: nerve pain following administration of Shingrix) (serious criteria other: serious as per reporter). The outcome of the rash and nerve pain were unknown. The reporter considered the rash and nerve pain to be related to Shingrix. The company considered the rash and nerve pain to be unrelated to Shingrix. Additional Information: GKS receipt date: 13-MAR-2025 The reporter reported that the patient recived Shingrix vaccine the dose number was unknown but, after vaccination patient experienced rash and nerve pain. The expiry date of Shingles vaccine was unknown. The provider sent the patient to several specialist (dermatologist and neurologist) to identify the cause. Their only conclusion was that it was probably Shingrix vaccine. The reporter asked if this was a known side effect. She said she had 2 events but only shared information for one patient.; Sender's Comments: Rash is a listed event which, due to the following criteria (insufficient information regarding medical history, concurrent conditions, concomitant medications, completion of primary vaccination schedule, time to onset) is considered unrelated to GSK vaccine Shingrix. Neuralgia is an unlisted event which is considered unrelated to GSK vaccine Shingrix. More
2832485 57 M NC 03/21/2025 MMR
 GLAXOSMITHKLINE BIOLOGICALS
Incorrect route of product administration Incorrect route of product administration
was given Priorix intramuscularly; This non-serious case was reported by a pharmacist via call cente... was given Priorix intramuscularly; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 57-year-old male patient who received MMR (Priorix) for prophylaxis. On 10-MAR-2025, the patient received Priorix (intramuscular). On 10-MAR-2025, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: was given Priorix intramuscularly). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-MAR-2025 The pharmacy manager stated a patient was given Priorix intramuscularly yesterday (day before reporting), which led to subcutaneous injection formulation administered by other route. No further details were provided. More
2832486 0.5 M TX 03/21/2025 IPV
 SANOFI PASTEUR
 W1C741M
Extra dose administered, No adverse event Extra dose administered, No adverse event
Vaxelis was administered and extra dose of ipv (ipol) was also administered on the same day with no ... Vaxelis was administered and extra dose of ipv (ipol) was also administered on the same day with no reported adverse event; Initial information received on 18-Mar-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old male patient who was administered with Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Hib Vaccine Conj (Menigococcal Protein), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid [Vaxelis] and extra dose of Poliomyelitis Vaccine (Inactivated) (IPOL) was also administered on the same day with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria Vaccine Toxoid, Hepatitis B Vaccine Rhbsag (Yeast), Hib Vaccine Conj (Menigococcal Protein), Pertussis Vaccine Acellular 5-Component, Polio Vaccine Inact 3v (Vero), Tetanus Vaccine Toxoid [Vaxelis] for Immunisation. On 14-Mar-2025, the patient received 0.5mL of suspect IPV (Vero), Suspension for injection (lot W1C741M, expiry date 17-Nov-2025; strength standard and frequency once) via intramuscular route in right thighfor Immunisation and Vaxelis was administered and extra dose of IPV (IPOL) was also administered on the same day with no reported adverse event (extra dose administered) (latency same day). Reportedly, Office Manager called reporting that a patient was given Vaxelis and then another IPV (IPOL) on the same day and would like to know the safety or any possible adverse reactions. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2832487 31 F NV 03/21/2025 MEN
 UNKNOWN MANUFACTURER
Extra dose administered, No adverse event Extra dose administered, No adverse event
patient got an extra dose of menquadfi with no reported adverse event; Initial information received ... patient got an extra dose of menquadfi with no reported adverse event; Initial information received on 18-Mar-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves 31 years old female patient who got an extra dose of meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis B vaccine for prophylactic vaccination (Immunisation). On 07-Sep-2024, the patient received an unknown dose of (dose 1) of suspect meningococcal A-C-Y-W135 (T conj) vaccine, Solution for injection then on 19-Jan-2025 she received (dose 2) of same vaccine both with (unknown strength, batch number and expiry date) via unknown route in unknown administration site and on 16-Mar-2025, patient received an extra dose of 0.5 ml (dose 3) of same vaccine, Solution for injection (lot number: U8194AA and expiry date 30-Sep-2027) (strength: standard, frequency: once) via intramuscular route in the left arm for prophylactic vaccination (Immunisation) with no reported adverse event (extra dose administered) (Latency: same day). Reportedly, They want to get some guidance in terms of if there is any side effects or any issues regarding an extra dose. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2832488 6 M AR 03/21/2025 UNK
 UNKNOWN MANUFACTURER
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
6 year old was administered flublok with no reported adverse event; Initial information received on ... 6 year old was administered flublok with no reported adverse event; Initial information received on 19-Mar-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 6 years old male patient who was administered with Influenza Trivalent Recombinant Vaccine [Flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection, (unknown strength and expiry date) lot number not reported via unknown route in unknown administration site for Immunisation with no reported adverse events (Inappropriate age at vaccine administration) (Latency same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Reportedly, She asked if the patient would get the regular Fluzone next season. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2832489 62 M NJ 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 rx#0397974-1911
Chills, Erythema, Pain, Swelling Chills, Erythema, Pain, Swelling
soreness, swelling, redness, chills soreness, swelling, redness, chills
2832490 38 F NJ 03/21/2025 FLU3
FLU3
FLU3
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 C2PH4
C2PH4
C2PH4
Arthralgia, Asthenia, Bursitis, Cartilage injury, Joint impingement; Joint range... Arthralgia, Asthenia, Bursitis, Cartilage injury, Joint impingement; Joint range of motion decreased, Magnetic resonance imaging abnormal, Magnetic resonance imaging joint, Paraesthesia, Rotator cuff syndrome; Shoulder injury related to vaccine administration More
Post vaccine bursitis (L) shoulder with impingement (SIRVA) -> resulting to pain, limited range o... Post vaccine bursitis (L) shoulder with impingement (SIRVA) -> resulting to pain, limited range of motion, weakness, & tingling / paresthesia . More
โœ“
2832491 1.33 F NC 03/21/2025 DTAP
HIBV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 Y7JC3
Y013471
Injected limb mobility decreased, Ultrasound scan normal; Injected limb mobility... Injected limb mobility decreased, Ultrasound scan normal; Injected limb mobility decreased, Ultrasound scan normal More
After vaccination patient would not bend knee on L leg. She will walk and bear weight but not bend k... After vaccination patient would not bend knee on L leg. She will walk and bear weight but not bend knee. No redness, swelling or bruising. No injury. Ultrasound done on 3/20/25 - No abnormality at injection site, hip or knee of left leg. More
2832493 65 F FL 03/21/2025 COVID19
COVID19
 MODERNA
MODERNA

Erythema, Injection site erythema, Injection site induration, Joint swelling, Pe... Erythema, Injection site erythema, Injection site induration, Joint swelling, Peripheral swelling; Pruritus, Skin warm More
VIAL 0188>1A Swollen, Red, hot, arm shoulder where vaccine given. After ice pack and tylenol Subs... VIAL 0188>1A Swollen, Red, hot, arm shoulder where vaccine given. After ice pack and tylenol Subsided Sat 4/17/21 Left arm, both 1st & 2nd Moderna 1st - Slight redness swelling day of 3/17/21, 1 week later, itching redness, swelling Left arm 2nd - reaction later in the day - next day very red swollen hardness in the are of shot. After ice pack & tylenol for 3 days, subsided. Have had only slight reaction to flu shot - some years, not all. Swelling, redness, hard. Only allergy: insect bites, especially bee sings. Never required Epi pen More
2832535 80 M IA 03/21/2025 COVID19
FLU3
PNC20
 MODERNA
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH


Death; Death; Death Death; Death; Death
Passed away while on Hospice care Passed away while on Hospice care
โœ“
2832536 93 F IA 03/21/2025 COVID19
 MODERNA
 3043332
Death Death
passed away on hospice care passed away on hospice care
โœ“
2832537 4 M IN 03/21/2025 HPV9
 MERCK & CO. INC.
 HPV9
Expired product administered Expired product administered
expired vaccine expired vaccine
2832538 13 M IN 03/21/2025 COVID19
 MODERNA
 3044079
Unevaluable event Unevaluable event
none none
2832539 75 F OH 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 7ZM55
Dyspnoea, Pain Dyspnoea, Pain
Patient was experiencing severe pain and shortness of breath, called the squad and went to the ER. ... Patient was experiencing severe pain and shortness of breath, called the squad and went to the ER. It was determined that the immunization was given in the acromion process. More
2832540 85 F GA 03/21/2025 PNC20
 PFIZER\WYETH
 LX4482
Extra dose administered Extra dose administered
PATIENT RECEIVED DUPLICATE VACCINE- SHE HAD ALREADY RECEIVED A PREVNAR20 ON 3/13/2023 AND IT WAS NOT... PATIENT RECEIVED DUPLICATE VACCINE- SHE HAD ALREADY RECEIVED A PREVNAR20 ON 3/13/2023 AND IT WAS NOT IN SYSTEM SO SHE RECEIVED PREVNAR 20 ON 3/19/2025 More
2832541 52 F IN 03/21/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH








Base excess negative, Bilirubin urine, Blood bicarbonate normal, Blood glucose i... Base excess negative, Bilirubin urine, Blood bicarbonate normal, Blood glucose increased, Blood lactic acid normal; Blood pH increased, Blood thyroid stimulating hormone decreased, CSF cell count normal, CSF glucose increased, CSF neutrophil count negative; CSF protein increased, CSF red blood cell count positive, Catheter placement, Chest X-ray normal, Coma scale normal; Computerised tomogram head normal, Computerised tomogram neck normal, Computerised tomogram spine abnormal, Condition aggravated, Fraction of inspired oxygen; Glucose urine present, Haemoglobin urine absent, Influenza A virus test negative, Influenza B virus test negative, Neck pain; Nitrite urine absent, Nuchal rigidity, Obesity, PCO2 decreased, PO2 increased; Protein urine absent, Scan with contrast normal, Seizure like phenomena, Specific gravity urine normal, Spinal osteoarthritis; Systemic inflammatory response syndrome, Tachycardia, Urine analysis, Urine ketone body present, Urobilinogen urine; Venous oxygen saturation decreased, White blood cell count increased, White blood cells urine negative, pH urine normal More
Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive ... Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive Performed By: DO on March 17, 2025 09:15 EDT Verified By: DO on March 17, 2025 09:15 EDT Encounter Info: Hospital, Inpatient, 03/16/25 - * Final Report * Subjective Patient seen and examined, relatively unchanged in PCU this morning. She is admitted yesterday for neck pain, this is SIRS, possible meningitis, she had an LP that showed colorless clear CSF with no elevated neutrophils. Glucose was elevated as was protein. Patient was started on meningitis protocol with acyclovir, full studies are pending. She has no new complaints. No other night events per nursing, she has not had repeat episodes of her nonepileptic activity. A.m. labs are pending. Objective Vitals and Measurements Vitals & Measurements most recent past 24 hours T: 36.6 ๏ฟฝC (Oral) TMIN: 36.6 ๏ฟฝC (Oral) TMAX: 36.7 ๏ฟฝC (Oral) BP: 123/75 HR: 120 (Monitored) RR: 19 SpO2: 96% Oxygen Therapy: Room air Oxygen Flow Rate: 2 (L/min) WT: 96.2 kg Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 96.2 kg 03/17/25 Previous Daily Weight: 94.5 kg 03/16/25 Difference from Previous: 1.700 kg BMI: 38.1 03/16/25 Obese (BMI 30-39.9) Patient Height Current Height: 157.5 cm 03/17/25 Nutritional Orders: NPO Advance as Tolerated, Start on: 03/17/25 3:15:00 EDT, Advance Diet to: 180 gm Carb per day Diet (1300-1600 Kcal, "No Fluid Restrictions" mL Nursing-NPO until after Dysphagia screening normal exam by RN (no diet or medication until completed). If dysphagia screening abnormal, change order to NPO and notify physician patient needs Speech Therapy for Dysphagia Eval and Treat ---------------------- Intake/Output I/O TOTALS ONLY - Last 24 hrs (0600-0559) from 03/16 - 03/17 Total Intake 3789.55 mL Total Output 1050.00 mL Balance 2739.55 mL Physical Exam Constitutional: No acute distress Respiratory: Lungs CTAB Cardiovascular: Tachycardic Regular rhythm Gastrointestinal: Soft, non-tender, non-distended Skin: Intact, warm, dry no rashes Neurologic: Alert & oriented x 3, no cognitive impairment, no focal deficits Positive nuchal rigidity Lines, Tubes, and Drains External Dwelling Catheter Catheter IV cannula Forearm Left 20 gauge PIV Assessment/Plan Anxiety and depression F41.9 DM (diabetes mellitus), type 2 E11.9 H/O: CVA (cerebrovascular accident) Z86.73 History of psychogenic nonepileptic seizure Z87.898 Hyperlipidemia E78.5 Hypertension I10 Neck pain M54.2 SIRS (systemic inflammatory response syndrome) R65.10 1. Neck pain M54.2 (possible viral meningitis) given high wbc and negative imaging on CT head/neck and cspine, will start atbx until meningitis can be fully ruled out. Given high protein and glucose on CSF studies will also continue acyclovir. holding off on pain medications at this time given she is sleepy from Ativan. once she has become more awake and if she c/o pain, will add pain regimen at that time. 2. SIRS (systemic inflammatory response syndrome) R65.10 Meets sirs criteria with tachycardia and elevated wbc e/o unknown given neck pain, there is suspicion of meningitis. blood cx pending LP attempted in ED and was unsuccessful will need to consult IR in the am will start meningitis and sepsis protocol. will need to deescalate atbx and if meningitis is ruled out. UA pending 3. History of psychogenic nonepileptic seizure Z87.898 seizures like activity noted in ED. Ativan given seizure precaution 4. Anxiety and depression F41.9 holding home Xanax for now given that she is somnolent from the ativan given in ED 5. DM (diabetes mellitus), type 2 E11.9 CDA protocol resume home Lantus 6. H/O: CVA (cerebrovascular accident) Z86.73 noted 7. Hyperlipidemia E78.5 resume home statin 8. Hypertension I10 resume home BB Admission Disposition Fluids: Normal Saline Lines: PIV Diet: NPO Code Status/Goals of Care Discussion: Full Code VTE ppx: Heparin Sub Q Dispo: Observation Anticipated Length of stay on admission: Less than 2 midnights Discharge Disposition: _Expect the patient to be medically ready for discharge in 2-3 days, pending patient vital signs (HR/BP/RR/T) are within stable discharge parameters, symptomatic improvement, adequate pain control, improvement of mentation back to baseline, culture result(s) and discharge antibiotic regimens are finalized, Improvement in labs Location: Plan for discharge to be determined after therapy evaluations Discharge Needs: None Case Management Engaged I spent greater than 50 minutes in the evaluation and management of this patient with more than 50% of the time spent counseling and/or coordinating care. I counseled the patient and/or family about the findings, differential diagnoses, my assessment, recommendations, and plan. I coordinated care with the multidisciplinary healthcare team. Code Status Resuscitation Status - Ordered -- 03/17/25 3:15:00 EDT, Full Code Medications Active Scheduled Inpatient Medications acyclovir, Injection, 680 mg, IVPB, Q8H, Indication: Other (MUST specify in Comments), Start: 03/17/25 04:00:00 aztreonam, Injection, 2 GM, IVPB, Q6H, Indication: PCN/Cephalosporin Severe Allergy, Start: 03/17/25 04:00:00 heparin (heparin 5,000 units/0.5 mL injectable solution), Injection, 5,000 Units, Subcutaneous, Q8H, Start: 03/17/25 04:00:00 insulin glargine (insulin glargine (Core Diabetes App)), Injection, 28 Units, Subcutaneous, QPM, Start: 03/17/25 21:00:00 vancomycin, Injection, 750 mg, IVPB, Q12H, Indication: Meningitis/CNS Infection, Start: 03/17/25 19:00:00 Vancomycin - Pharmacy Dosing Consult, Miscellaneous, 1 Each, N/A, Daily, Indication: Meningitis/CNS Infection, Start: 03/17/25 03:15:00 Sodium Chloride 0.9% 1,000 mL IV Continuous 100 mL/hr 0 03/17/25 Dextrose 10% in Water 500 mL IV Continuous PRN interruption in TF/TPN at 80 mL/hr, per CDA One-Time Medications Given 03/16/25 00:00:00 TO 03/17/25 09:15:01 ceftRIAXone, Injection, 2 GM, IV Push, ONCE, (1 DOSE 03/17/25 00:53:00) dexamethasone, Injection, 10 mg, IV Push, ONCE, (1 DOSE 03/16/25 21:36:00) fentaNYL, Injection, 50 mCg, IV Push, ONCE, (1 DOSE 03/16/25 09:03:00) HYDROmorphone (HYDROmorphone Inj ED (1 mg/mL)), Injection, 0.5 mg, IV Push, ONCE, (1 DOSE 03/16/25 21:36:00) Lactated Ringers (LR Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 03/16/25 08:55:00) Lactated Ringers (LR Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 03/16/25 09:36:00) Lactated Ringers (LR Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 03/16/25 13:41:00) lidocaine topical (lidocaine 5% topical film), Patch, 1 Patch, Topical, ONCE, (1 DOSE 03/16/25 09:03:00) LORazePAM, Injection, 2 mg, IV Push, Ad Hoc ONCE, (1 DOSE 03/16/25 09:14:00) methocarbamol, Tablet, 1,000 mg, Orally, ONCE, (1 DOSE 03/16/25 10:27:00) MIDazoLAM, Injection, 2.5 mg, IV Push, ONCE, (1 DOSE 03/16/25 13:49:00) MIDazoLAM, Injection, 2.5 mg, IV Push, ONCE, prn, Anxiety, (1 DOSE 03/16/25 21:41:00) ondansetron, Injection, 4 mg, IV Push, ONCE, (1 DOSE 03/16/25 21:36:00) piperacillin-tazobactam, Injection, 4.5 GM, IV Push, ONCE, (1 DOSE 03/16/25 09:45:00) piperacillin-tazobactam, Injection, 3.375 GM, IVPB, ONCE, (1 DOSE 03/16/25 15:00:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% Bolus), Infusion, 500 mL, IVPB, ONCE, (1 DOSE 03/16/25 21:36:00) vancomycin, Injection, 2 GM, IVPB, ONCE, (1 DOSE 03/16/25 09:43:00) vancomycin, Injection, 2 GM, IVPB, ONCE, (1 DOSE 03/17/25 06:49:00) PRN Medications (0600 - 0559) from 03/16 - 03/17 acetaminophen, 650 mg, Orally, Q4H, 0 Dose(s) glucagon, 1 mg, IM, Unscheduled, 0 Dose(s) glucose, Per Core Diabetes App , IV Push, Unscheduled, 0 Dose(s) insulin lispro, Per Core Diabetes App , Subcutaneous, Unscheduled, 0 Dose(s) ondansetron, 4 mg, IV Push, Q6H, 0 Dose(s) polyethylene glycol 3350, 17 GM, Orally, Daily, 0 Dose(s) Lab Results All Labs Last 24 hours (No Micro or Pathology) Chemistry: Lactate Venous Pl QN: 1.7 mmol/L (03/16/25 09:36:00) Gluc-Strip, POC: 197 mg/dL High (03/17/25 07:33:00) pH Bld Venous QN: 7.46 High (03/16/25 09:36:00) PCO2 Bld Venous QN: 33 mmHg Low (03/16/25 09:36:00) PO2 Bld Venous QN: 52 mmHg High (03/16/25 09:36:00) Base Excess Bld Venous: 0 mmol/L (03/16/25 09:36:00) Bicarb Bld Venous Calc: 24 mmol/L (03/16/25 09:36:00) O2 Sat Bld Venous Calc: 88 % (03/16/25 09:36:00) FIO2: Venous (03/16/25 09:36:00) Patient Temperature: 37 DegC (03/16/25 09:36:00) TSH 3rd Gen SerPl QN: 1.047 mcU/mL (03/17/25 04:20:00) Urine Studies: Color: Light-Yellow (03/17/25 04:20:00) Clarity: Clear (03/17/25 04:20:00) Specific Gravity: 1.02 (03/17/25 04:20:00) pH: 5.5 (03/17/25 04:20:00) Protein: NEGATIVE (03/17/25 04:20:00) Glucose: 500 Abnormal (03/17/25 04:20:00) Ketones: 40 Abnormal (03/17/25 04:20:00) Bilirubin: NEGATIVE (03/17/25 04:20:00) Hgb Ur: NEGATIVE (03/17/25 04:20:00) Nitrite: NEGATIVE (03/17/25 04:20:00) Urobilinogen: Normal (03/17/25 04:20:00) Leukocyte Esterase Ur: NEGATIVE (03/17/25 04:20:00) All Other Labs: Tube Number CSF: 3 (03/16/25 22:22:00) Color CSF: COLORLESS (03/16/25 22:22:00) Clarity CSF: Clear (03/16/25 22:22:00) Xanthochromia CSFld: COLORLESS (03/16/25 22:22:00) TNC CSF: 1 /cumm (03/16/25 22:22:00) TNC CSF Uncorrected: 1 /cumm (03/16/25 22:22:00) RBC CSF: 1 /cumm (03/16/25 22:22:00) Glucose CSF QN: 79 mg/dL High (03/16/25 22:22:00) Protein CSF QN: 54 mg/dL High (03/16/25 22:22:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (03/16/25 08:50:00) Rapid Influenza A PCR: Not Detected (03/16/25 08:50:00) Rapid Influenza B PCR: Not Detected (03/16/25 08:50:00) Diagnostics Radiology Results - Last 24 hours Across Visits 03/16/2025 09:24 - XR Chest PA or AP Portable IMPRESSION:1. No evidence of acute process or significant interval change. Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us at (redacted) with any questions. 03/16/2025 11:47 - CT Head W/o IV Contrast IMPRESSION: No evidence of acute intracranial hemorrhage, parenchymal edema, significant intracranial mass effect or calvarial fracture. Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us at (redacted) with any questions. 03/16/2025 12:17 - CTA Head/Neck W/IV Contrast IMPRESSION:CTA HEAD:1. Normal CT angiogram of the intracranial arteries. 2. Specifically, no occlusion, stenosis or aneurysm. CTA NECK:1. Normal CT angiogram of the neck. 2. Specifically, no calcified plaques, occlusion, stenosis or dissection. Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us at (redacted) with any questions. 03/16/2025 12:17 - CT Cervical Spine W/o IV Contrast IMPRESSION: 1. Study limited due to streak artifact.2. No acute osseous abnormality.3. Scattered degenerative changes. No significant spinal canal or neural foraminal stenosis. Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us at (redacted) with any questions. Signature Line Electronically Signed on 03/17/25 09:15 EDT ________________________________________________________ DO More
โœ“
2832542 81 F IN 03/21/2025 FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
U8532CA
Alanine aminotransferase normal, Anion gap, Anxiety, Arthritis, Aspartate aminot... Alanine aminotransferase normal, Anion gap, Anxiety, Arthritis, Aspartate aminotransferase normal; Asthenia, Asthma, Bacterial test negative, Basophil count decreased, Basophil percentage decreased; Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal, Blood chloride normal; Blood cholesterol increased, Blood creatinine increased, Blood culture, Blood glucose normal, Blood lactic acid decreased; Blood potassium normal, Blood sodium normal, Blood urea increased, Brain natriuretic peptide normal, Bronchitis; Carbon dioxide normal, Chest X-ray abnormal, Chromaturia, Creatinine renal clearance decreased, Depression; Dyspnoea, Eosinophil count decreased, Eosinophil percentage decreased, Fatigue, Glomerular filtration rate decreased; Glucose urine absent, Haematocrit normal, Haemoglobin normal, Haemoglobin urine absent, Hypovolaemia; Hypoxia, Influenza, Influenza A virus test positive, Influenza B virus test, Influenza virus test negative; Lymphocyte count normal, Lymphocyte percentage decreased, Malaise, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal; Mean cell volume normal, Mean platelet volume normal, Monocyte count normal, Monocyte percentage, Multiple organ dysfunction syndrome; Nausea, Neutrophil count normal, Neutrophil percentage increased, Nitrite urine absent, Oedema; Oropharyngeal pain, Peripheral swelling, Platelet count normal, Productive cough, Protein total normal; Protein urine present, Rales, Red blood cell count normal, Red blood cells urine, Red cell distribution width increased; Respiratory tract congestion, SARS-CoV-2 test negative, Sepsis, Septic shock, Specific gravity urine normal; Sputum discoloured, Troponin I increased, Urinary casts, Urinary squamous epithelial cells increased, Urine analysis normal; Urine bilirubin decreased, Urine ketone body absent, Urobilinogen urine decreased, White blood cell count normal, White blood cells urine; White blood cells urine negative, pH urine normal More
Document Type: History and Physical Document Subject: History & Physical Note Performed By: ... Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on March 20, 2025 16:26 EDT Verified By: MD on March 20, 2025 17:54 EDT Encounter Info: Hospital, Inpatient, 03/20/25 - * Final Report * History of Present Illness/Subjective 81 year old female with past medical history of asthma, HTN, HLD, CKD, presents to the ED for malaise, dyspnea/hypoxia that started few days prior to presentation. According to the patient, she was in her usual state of health until about few days when she noticed shortness of breath and tiredness. Shortness of breath is associated with cough productive of white sputum, congestion and sore throat. She also endorsed nausea but denies vomiting. No diarrhea or constipation. no fever or chills. She denied any sick contacts or recent travel. In the ER Vital signs Blood pressure 98/58, heart rate 90, respiratory rate 20, SpO2 94% on 4 L Labs WBC 9.4, hemoglobin 15.3, platelets 196, sodium 138, potassium 4.2, bicarb 102, BUN/creatinine 27/1.48, glucose 165, lactic venous 3.0 Urinalysis unremarkable COVID-negative Flu AB-positive Imaging Chest x-ray 1. Coarse lower lung markings may indicate bronchitis, reactive airways disease or early congestive changes. 2. No consolidating infiltrates or other acute findings. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Physical Exam/Objective Vitals & Measurements most recent past 24 hours Hemodynamics Neurologic Patient Weight Patient Height None Reported General: Alert and oriented, No acute distress. Eye: Normal conjunctiva. Cardiovascular: Regular rate, Normal rhythm, No murmur. Respiratory: diffuse rales to auscultation, Respirations are non-labored. Gastrointestinal: Soft, Non-tender, Non-distended, Normal bowel sounds, No organomegaly. Neurologic: Alert, Oriented, non focal Psychiatric: Cooperative, Appropriate mood & affect. Musculoskeletal: bilat leg swelling, ???????L UE swelling Assessment/Plan 1. Shortness of breath R06.02 2. Hypoxia R09.02 3. Acute bronchitis J20.9 4. Influenza A J10.1 81-year-old man with a history of hyperlipidemia, prediabetes, stage III CKD presents to the ER due to generalized weakness with labs showing positive flu A and patient is requiring 4 L of oxygen through nasal cannula. Baseline is room air. Diffuse Rales noticed on auscultation Will start renal dose Tamiflu Continue oxygen supplementation and wean as able RT eval to follow Prednisone DuoNebs as needed Airborne isolation 5. AKI (acute kidney injury) N17.9 Likely prerenal from hypovolemia Will minimize use of potentially nephrotoxic agents to the extent possible, and will monitor urine output and labs. Low threshold to involve nephrology if renal function worsens. Gentle hydration Hold Lasix and lisinopril 6. Anxiety and depression F41.9 Chronic. 7. History of Roux-en-Y gastric bypass Z98.84 Noted 8. Hypertension I10 Blood pressure currently soft. Hold blood pressure medications 9. History of breast cancer Z85.3 Noted. Significant left arm swelling noted. Patient endorsed it is chronic as a result of left mastectomy Outpatient follow-up with oncologist 10. Prediabetes R73.03 Obtain A1c 11. Stage 3 chronic kidney disease N18.30 12.Severe sepsis Inpatient Sepsis Bundle Care: Sepsis Bundle was Started in the Emergency Department Sepsis with End Organ dysfunction _ Source _ Associated End Organ Dysfunction _ Associated Underlying Device _ Drug Resistance Unknown at this time Patient has chronic organ dysfunction as evidenced by _ Initial Lactate Done IF Initial Lactate >2, Repeat Lactate Auto ordered if applicable IF 2nd lactate greater than initial, continue to trend Lactate Levels, Auto Ordered if applicable Antibiotics Started in the Emergency Department, YES Blood Cultures Collected prior to Antibiotic start, YES Target Volume=30mg/kg Crystalloid Fluids 30mg/kg Crystalloid Fluids were given in the Emergency Department YES. IF NO, reason _ , Instead _ Septic Shock is present on admission NO Vasopressor(S) were initiated in the Emergency Department, N/A Sepsis Reassessment/Review of Systems completed at _ Greater than 5???????5 minutes total with greater than 50% of time face-to-face with patient reviewing course, plan of care, and in care coordination Code Status None Recorded Chronic Problem List Acid reflux Anxiety and depression Arthritis of right knee Asthma Edema Encounter for follow-up High cholesterol History of breast cancer History of Roux-en-Y gastric bypass History of total left knee replacement Hypertension Left shoulder pain Meningioma Morbid obesity Osteoarthritis of left shoulder Prediabetes Right shoulder pain Stage 3 chronic kidney disease Umbilical hernia Ventral incisional hernia Procedure/Surgical History ?Total knee replacement (10/23/2023) ?back surgery x2 ?Bilateral cataracts ?bilateral foot surgery ?Bunionectomy ?Cataract ?Cholecystectomy ?Gallbladder ?Gastric bypass ?H/O: hysterectomy ?Heel ?History of left mastectomy ?Knee ?Left reverse total shoulder arthroplasty 02/15/24 ?Mastectomy ?nose surgery ?Thyroid surgery Surgical History Internal 10/23/2023 Knee Arthroplasty (Left) , MD Medications Home Medications (13) Active allopurinol 300 mg oral tablet 300 mg = 1 Tablet, Orally, QAM amLODIPine 5 mg oral tablet 5 mg = 1 Tablet, Orally, QAM DME (Vendor) Walker See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. furosemide 40 mg oral tablet 40 mg = 1 Tablet, Orally, QAM lisinopril 10 mg oral tablet lovastatin 40 mg oral tablet 40 mg = 1 Tablet, Orally, QAM magnesium oxide See Instructions, Orally montelukast 10 mg oral tablet 10 mg = 1 Tablet, Orally, QAM omeprazole 20 mg oral delayed release capsule 20 mg = 1 Capsule, Orally, QAM OXYcodone 5 mg oral tablet 5 mg = 1 Tablet, PRN, Orally, Q4H PARoxetine 20 mg oral tablet 20 mg = 1 Tablet, Daily Tylenol 1,000 mg, PRN, Orally, Q6H Ventolin HFA 90 mCg/inh inhalation aerosol 2 Puff, PRN, Inhalation, Q4H Active Scheduled Inpatient Medications None Reported One-Time Medications Given 03/19/25 00:00:00 TO 03/20/25 16:25:47 None Reported PRN Medications (0600 - 0559) from 03/19 - 03/20 None Reported Allergies Cats (Difficulty Breathing) mixed grass pollens allergen extract (Unknown) Social History Alcohol Current, 1-2 times per year Electronic Cigarette/Vaping E-Cigarette Use Never. Home/Environment Lives with Siblings. Sexual Orientation and Gender Identity Which of the following do you identify most closely with? (check all that apply) Heterosexual (or straight). What is your current gender identity? (check all that apply) Female. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Cancer: Mother, Sister and Brother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 9.4 k/cumm (03/20/25 13:39:00) RBC: 5.02 million/cumm (03/20/25 13:39:00) Hgb: 15.3 GM/dL High (03/20/25 13:39:00) Hct: 46.4 % (03/20/25 13:39:00) MCV: 93 fL (03/20/25 13:39:00) MCH: 30.6 pg (03/20/25 13:39:00) MCHC: 33.1 GM/dL (03/20/25 13:39:00) RDW: 16.6 % High (03/20/25 13:39:00) Platelet: 196 k/cumm (03/20/25 13:39:00) MPV: 8.8 fL (03/20/25 13:39:00) Neutrophils %: 80 % (03/20/25 13:39:00) Lymphocytes %: 13 % (03/20/25 13:39:00) Monocytes %: 6 % (03/20/25 13:39:00) Eosinophils %: 0 % (03/20/25 13:39:00) Basophils %: 0 % (03/20/25 13:39:00) Absolute Neutrophil: 7.5 k/cumm (03/20/25 13:39:00) Absolute Lymphocyte: 1.2 k/cumm (03/20/25 13:39:00) Absolute Monocyte: 0.6 k/cumm (03/20/25 13:39:00) Absolute Eosinophil: 0 k/cumm (03/20/25 13:39:00) Absolute Basophil: 0 k/cumm (03/20/25 13:39:00) Chemistry: Sodium SerPl QN: 138 mmol/L (03/20/25 13:39:00) Potassium SerPl QN: 4.2 mmol/L (03/20/25 13:39:00) Chloride SerPl QN: 102 mmol/L (03/20/25 13:39:00) Carbon Dioxide SerPl QN: 26 mmol/L (03/20/25 13:39:00) Anion Gap: 10 mmol/L (03/20/25 13:39:00) BUN SerPl QN: 27 mg/dL High (03/20/25 13:39:00) Creatinine SerPl QN: 1.48 mg/dL High (03/20/25 13:39:00) Estimated GFR (CKD-EPI, no race): 35 mL/min/1.73m2 Low (03/20/25 13:39:00) Estimated CRCL (CG): 34 mL/min Low (03/20/25 13:39:00) Glucose SerPl QN: 165 mg/dL High (03/20/25 13:39:00) Calcium Total SerPl QN: 9.1 mg/dL (03/20/25 13:39:00) Alkaline Phos SerPl QN: 85 Units/L (03/20/25 13:39:00) ALT SerPl QN: 10 Units/L (03/20/25 13:39:00) AST SerPl QN: 15 Units/L (03/20/25 13:39:00) Bilirubin Total SerPl QN: 0.7 mg/dL (03/20/25 13:39:00) Total Protein SerPl QN: 7.6 GM/dL (03/20/25 13:39:00) Albumin SerPl QN: 4.2 GM/dL (03/20/25 13:39:00) Troponin-I High Sensitivity: 6 ng/L (03/20/25 15:08:00) BNP Pl QN: 46 pg/mL (03/20/25 13:39:00) Lactate Venous Pl QN: 3 mmol/L High (03/20/25 13:39:00) Urine Studies: Color: Yellow (03/20/25 14:50:00) Clarity: Clear (03/20/25 14:50:00) Specific Gravity: 1.015 (03/20/25 14:50:00) pH: 5.5 (03/20/25 14:50:00) Protein: 30 Abnormal (03/20/25 14:50:00) Glucose: Normal (03/20/25 14:50:00) Ketones: NEGATIVE (03/20/25 14:50:00) Bilirubin: NEGATIVE (03/20/25 14:50:00) Hgb Ur: NEGATIVE (03/20/25 14:50:00) Nitrite: NEGATIVE (03/20/25 14:50:00) Urobilinogen: Normal (03/20/25 14:50:00) Leukocyte Esterase Ur: NEGATIVE (03/20/25 14:50:00) WBC: 0-5 (03/20/25 14:50:00) RBC: 0-2 (03/20/25 14:50:00) Bacteria: NONE (03/20/25 14:50:00) Squamous Epithelial: Few (03/20/25 14:50:00) Hyaline Casts: 0-2 (03/20/25 14:50:00) Misc UA Micro: Misc UA Micro (03/20/25 14:50:00) All Other Labs: COVID 19 Specimen Source: Nasopharyngeal (03/20/25 13:41:00) Coronavirus SARS-CoV2 Rapid: Not Detected (03/20/25 13:41:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (03/20/25 13:41:00) Rapid Influenza A PCR: Detected Abnormal (03/20/25 13:41:00) Rapid Influenza B PCR: Not Detected (03/20/25 13:41:00) Diagnostics Radiology Results - Last 24 hours Across Visits 03/20/2025 14:02 - XR Chest PA or AP Portable IMPRESSION:1. Coarse lower lung markings may indicate bronchitis, reactiveairways disease or early congestive changes.2. No consolidating infiltrates or other acute findings. Signature Line Electronically Signed on 03/20/25 17:54 EDT ________________________________________________________ MD More
โœ“
2832543 28 F FL 03/21/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 L5229
Inappropriate schedule of product administration Inappropriate schedule of product administration
Vaccine administered before next required dose. Next dose was due in 2031, but was given in 2025. Vaccine administered before next required dose. Next dose was due in 2031, but was given in 2025.
2832544 4 F MN 03/21/2025 DTAPIPV
MMRV
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 5G23D
Y014308
Injection site erythema, Injection site pruritus; Injection site erythema, Injec... Injection site erythema, Injection site pruritus; Injection site erythema, Injection site pruritus More
Localized redness/itching at Kinrix injection site. Provider noted redness extended 10-12 cm vertica... Localized redness/itching at Kinrix injection site. Provider noted redness extended 10-12 cm vertically and 6-8 cm horizontally, no fluctuance or axillary lymph node swelling. Provider indicated to the family that sx should be resolved within 3-5 days and that it is not likely to progress to a systemic allergy. Okay to receive future tetanus containing vaccines. More
2832545 16 F IN 03/21/2025 HEPA
IPV
MMR
MNQ
TDAP
VARCEL
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
MERCK & CO. INC.
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 T5727
X1C891M
Y004114
U8271AC
LX494
Y013346
Rash; Rash; Rash; Rash; Rash; Rash Rash; Rash; Rash; Rash; Rash; Rash
2 days after being vaccinated, patient developed a rash on the back of both her hands. No other symp... 2 days after being vaccinated, patient developed a rash on the back of both her hands. No other symptoms reported More
2832546 3 M PA 03/21/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
Rash, Rash pruritic Rash, Rash pruritic
Mom states itchy rash on feet morning after vaccination. Mom states itchy rash on feet morning after vaccination.
2832547 72 M WI 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 fj9a7
Extra dose administered Extra dose administered
patient received third dose for a 2 dose series patient received third dose for a 2 dose series
2832548 85 F NY 03/21/2025 COVID19
COVID19
COVID19
RSV
RSV
RSV
RSV
RSV
RSV
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
PFIZER\WYETH
PFIZER\WYETH





HN3790
HN3790
HN3790
Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign bod... Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign body, Stomatitis; Aphonia, Blood test, Chest X-ray, Dysphonia; Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign body, Stomatitis; Aphonia, Blood test, Chest X-ray, Dysphonia; Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign body, Stomatitis; Aphonia, Blood test, Chest X-ray, Dysphonia More
I thought maybe i was getting an asthma attack it felt heavy like an elephant was on it. Then my voi... I thought maybe i was getting an asthma attack it felt heavy like an elephant was on it. Then my voice got raspy and my husband told me i caught a cold. From then on i started noticing that my mouth was dry and i had no taste. My tongue is all cut up. I have a lump under my voice box it feels like there is something in there. And i have a sore inside of my right cheek the other night, and after a couple of hours it went down by itself. I still have an appetite. I also went to ENT Dr. 11/27/24, 12/03/24, 01/08/25 and i went to the doctors in (redacted) 03/10/25. More
2832549 03/21/2025 COVID19
COVID19
RSV
RSV
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS



Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign bod... Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign body, Stomatitis; Ageusia, Discomfort, Dry mouth, Dysphonia, Glossodynia; Sensation of foreign body, Stomatitis More
I thought maybe i was getting an asthma attack it felt heavy like an elephant was on it. Then my voi... I thought maybe i was getting an asthma attack it felt heavy like an elephant was on it. Then my voice got raspy and my husband told me i caught a cold. From then on i started noticing that my mouth was dry and i had no taste. My tongue is all cut up. I have a lump under my voice box it feels like there is something in there. And i have a sore inside of my right cheek the other night, and after a couple of hours it went down by itself. I still have an appetite. I also went to ENT Dr. 11/27/24, 12/03/24, 01/08/25 and i went to the doctors in (redacted) 03/10/25. More
2832550 34 F NY 03/21/2025 HPV9
 MERCK & CO. INC.
Hypoaesthesia, Paraesthesia Hypoaesthesia, Paraesthesia
Tingling and numbing over entire body. No treatment yet. Tingling and numbing over entire body. No treatment yet.
๐Ÿ“‹ Privacy Policy & Data Disclaimer